Breaking News
Get 45% Off 0
🤼 As an investor, what do I need to know about US/China trade negotiations right now?
Ask WarrenAI
Close

Euromobiliare Science 4 Life A (0P000146HQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6.560 -0.014    -0.21%
08/05 - Closed. Currency in EUR
Type:  Fund
Market:  Italy
ISIN:  IT0005046054 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 280.15M
Euromobiliare Science 4 Life A 6.560 -0.014 -0.21%

0P000146HQ Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Euromobiliare Science 4 Life A (0P000146HQ) fund. Our Euromobiliare Science 4 Life A portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 10.920 11.690 0.770
Shares 49.440 49.440 0.000
Bonds 38.320 47.540 9.220
Convertible 1.330 1.330 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 17.967 16.280
Price to Book 3.657 2.446
Price to Sales 2.251 1.838
Price to Cash Flow 12.108 9.954
Dividend Yield 2.143 2.455
5 Years Earnings Growth 8.803 10.870

Sector Allocation

Name  Net % Category Average
Healthcare 57.680 11.901
Consumer Defensive 11.490 7.397
Industrials 9.610 12.223
Utilities 7.730 3.030
Consumer Cyclical 6.310 12.053
Basic Materials 2.930 6.970
Technology 2.890 19.408
Financial Services 1.080 16.176
Real Estate 0.280 2.760

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Australasia
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 345

Number of short holdings: 19

Name ISIN Weight % Last Change %
  Eli Lilly US5324571083 2.42 734.24 -2.29%
  Novo Nordisk B DK0062498333 1.55 444.3 +3.59%
  UnitedHealth US91324P1021 1.45 380.64 -1.27%
  AstraZeneca GB0009895292 1.42 10,240.0 +1.05%
  AbbVie US00287Y1091 1.16 184.60 -0.53%
  Nestle CH0038863350 1.15 87.65 +0.68%
  Roche Holding Participation CH0012032048 1.01 257.60 -0.88%
  Novartis CH0012005267 1.01 90.91 -0.22%
  Sanofi FR0000120578 0.97 92.92 +1.26%
  Boston Scientific US1011371077 0.92 102.86 -0.42%

Top Equity Funds by Euromobiliare Asset Management SGR SpA

  Name Rating Total Assets YTD% 3Y% 10Y%
  Euromobiliare Flessibile Allocazion 620.47M -3.49 3.04 1.48
  LU0284571469 328.66M -13.26 4.31 4.58
  Euromobiliare Azioni Internazionali 459.38M -4.53 4.38 3.36
  Euromobiliare TR Flex Value A 355.41M 0.14 1.72 0.27
  Euromobiliare Progetto 2021 Atto ii 350.74M 0.55 5.17 -
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P000146HQ Comments

Write your thoughts about Euromobiliare Science 4 Life A
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email